Evaluation of insulin resistance in adolescent girl with menstrual irregularities


  • Simi Kumari Department of Gynaecological Oncology, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, India
  • Sangeeta Pankaj Department of Gynaecological Oncology, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, India
  • Archana Sinha Department of Gynaecological Oncology, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, India
  • Dipali Prasad Department of Gynaecological Oncology, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, India
  • Ritesh Kumar Department of Anaesthesiology & Critical Care, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, India




PCOS, Insulin resistance, HOMA-IR, Menstrual irregularities


Background: Polycystic ovary syndrome is most commonly recognized endocrinopathy in reproductive age group. The symptoms of PCOS vary with age, race, weight, and medications, which lead to the challenges of accurate diagnosis particularly in adolescent age group. Adolescent with PCOS most commonly encountered by gynecologist, for their menstrual irregularities. During early puberty, menstrual irregularities can occur normally due to immature Hypothalamo-pituitary-ovarian axis. Early detection of PCOS is required to control high risk of insulin resistance followed by reproductive and metabolic consequences latter on in life. Also diabetes mellitus is asymptomatic at early stage of insulin resistance and impaired glucose tolerance. Few studies have been conducted in Indian population, for prevalence of insulin resistance and metabolic syndrome in adolescents with PCOS, with varying results and hence further study is required. The aim and objectives of the study was to evaluate the presence of insulin resistance in adolescents with menstrual disorders persisting 2 years after menarche.

Methods: A Cross sectional Study consisting of 102 adolescent girls done in Gynecology Outpatient Clinic of the Indira Gandhi Institute Of Medical Science Biochemical analysis was done on(day 3 to day 5) of menstruation for clinical/laboratory hyperandrogenism ,and various cause of anovulation. HOMA-IR value was evaluated for insulin resistance by following formula: fasting serum insulin (μU/ml) × fasting plasma glucose (m mol/l)/22.5. The 2003 Rotterdam consensus workshop criteria were used for ultrasonographic feature of polycystic ovarian syndrome.

Results: Most common pattern of menstrual irregularities was Oligomenorrhea. 4 (7.84%) cases had insulin resistance (HOMA-IR >3.9) and 25 (49.01%) cases had elevated HOMA-IR values (HOMA-IR >1). PCOS was seen in 35.29% of cases and only 1.96% of control.

Conclusions: Adolescents with persistent menstrual irregularities even after two year of menarche, especially with oligomenorrhea and hypomenorrhoea, more frequently have the diagnosis of PCOS and also present with elevated HOMA-IR values.


Fauser BC, Tarlatzis BC, Rebar RW. Consequences on women’s health aspect of polycystic ovary syndrome(pcos):The Amsterdam ESHRE/ASRM-sponscered 3rd PCOS consequences workshop Group. Fertil Stenil. 2012;28-38.e25.

March WA, Mooe VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544-51.

Franks S. Polycystic ovary syndrome in adolescents; Int J obesity. 2008;32:1035-41.

Rosenfield RL. Clinical review: Adolescent anovulation: maturational mechanisms and implication. J Cin Endocrinol Metab. 2013;98(9):3572-83.

Bonny AE, Appelbam H, Connor EL. Clinical variability in approach to polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2012;25:259-61.

Robinson S, Kiddy D, Gelding SV. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin endocrinol. 1993;39(3):351-5.

Avvad CK, Holeuwerger R, Silva VCG. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence. Gynecol Endocrinol. 2001;15:170.

Nestler JE. Insulin regulation of human ovarian androgens; hum reprod. 1997;12(supplement 1).

ESHRE Rotterdam workshop group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41.

Driscoll DA. Polycystic ovary syndrome in adolescence. Semin Reprod Med. 2003;21:301.

Acie´n P, Quereda F, Matallı´n P. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril. 1999;72:32.

Geffner ME, Kaplan SA, Bersch N. Persistence of insulin resistance in polycystic ovary disease after inhibition of ovarian steroid secretion. Fertil Steril. 1986;45:327.

Dunaif A, Finegood DT. B-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81:942-7.

Ciaraldi TP, Roiey AE, Madar RZ: Cellular mechanism of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 1992;75:577.

Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1165-74.

Dunaif A, Segal KR, Shelly DR. Evidence for distinctive and intrinsic defects in insulin action in the polycystic ovary syndrome. Diabetes. 1992;41:1257-66.

Poretsky L. On the paradox of insulin induced hyperandrogenism in insulin resistance states. Endocr Rev. 1991;12:3.

Marcel HA, Van Hooff MD, Voorhorst FJ. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin. Fertil Steril. 2000;74:49.

Falsetti L, Eleftheriou G. hyperinsulinemia in the polycystic ovary syndrome: a clinical, endocrine and echographic study in 240 patients. Gyenecol endocrinol. 1996;10(5):319-26.

Radikova Z. Assessment of insulin sensitivity/resistance in epidemiological studies. Endocrine regulations. 2003;37:189-94.

Roy S, Srivastava TG. An update on polycystic ovary syndrome-its investigation and management; some researchable issues. Health and population-perspectives and issues. 2004;27(3):126-65.

Mohan BS. Correlations between fasting glucose: insulin ratio, serum triglyceride level, and triglyceride: high-density lipoprotein cholesterol ratio in adolescent girls with polycystic ovarian syndrome. J obstet gynecol India. 2005;55(3):254-6.

Dangal G. Menstrual disorders in adolescents; the internet journal of gynecology and obstetrics. 2005;4(1).

Lewy Vered D, Danadian K, Witchel SF. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr. 2001;138:38.

Matthews DR, Hosker JR. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.

Katsuki A, Sumida Y, Gabazza EC. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes care. 2001;24:362-5.

Catherine M. D., Alfred A. Bartolucci, and Ricardo Azziz: prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertility and Sterility. 2005;83(5):1454-60.

Nobels F, Dewailly D. Puberty and polycystic ovarian syndrome: The insulin-like growth factor I hypothesis. Fertil Steril. 1992;58:655.

Ehrmann DA, Barnes RB, Rosenfield RL. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovarian syndrome. Diabetes Care. 1999;22:141.

Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrinol Rev. 1997;18:774.

Holte J, Bergh T, Berne Ch, Berglund L, Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 1994;78:1052-8.

Ibanez L, Potau N, Zampolli M. Hyper-insulinemia in post pubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1996;81:1237.

Kelly CJ, Stenton SR, Lashen H, insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-analysis. Human reproduction update. 2011;17(1):4-16.

Dunaif A, Xia J. excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle a potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest. 1995;96:801-10.

De Fronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214.

Apter D, Butzow T, Laughlin GA. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. Clin Endocrinol Metab. 1995;80:2966.

Matthews DR, Hosker JR. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.






Original Research Articles